Skip to content

Clinical study of blood purification therapy in critical care in Japan: Results from the survey research of the Japan Society for Blood Purification in Critical Care in 2013

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000027678
Enrollment
2000
Registered
2017-06-07
Start date
2013-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases treated with blood purification therapy

Interventions

None listed

Sponsors

The Survey Committee, Japan Society for Blood Purification in Critical Care
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients treated with blood purification therapy between January 1 and December 31 2012.

Exclusion criteria

Exclusion criteria: aged <20 years old, and those whose records regarding date of birth, mode of blood purification therapy, primary disease, or outcome were incomplete

Design outcomes

Primary

MeasureTime frame
The number of the patients treated with blood purification, diseases needed for blood purification therapy, and survival rate

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026